DK137392C - Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination - Google Patents

Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Info

Publication number
DK137392C
DK137392C DK447972A DK447972A DK137392C DK 137392 C DK137392 C DK 137392C DK 447972 A DK447972 A DK 447972A DK 447972 A DK447972 A DK 447972A DK 137392 C DK137392 C DK 137392C
Authority
DK
Denmark
Prior art keywords
prevaccination
vira
copd
vaccinia
vaccination
Prior art date
Application number
DK447972A
Other languages
Danish (da)
English (en)
Other versions
DK137392B (da
Inventor
A H Stickl
Original Assignee
Bayern Freistaat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by Bayern Freistaat filed Critical Bayern Freistaat
Publication of DK137392B publication Critical patent/DK137392B/da
Application granted granted Critical
Publication of DK137392C publication Critical patent/DK137392C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK447972A 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination DK137392C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (2)

Publication Number Publication Date
DK137392B DK137392B (da) 1978-02-27
DK137392C true DK137392C (da) 1978-09-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447972A DK137392C (da) 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Country Status (5)

Country Link
AT (1) AT320149B (enExample)
BE (1) BE787901A (enExample)
CH (1) CH568392A5 (enExample)
DK (1) DK137392C (enExample)
ES (1) ES406590A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
EP2264178A1 (en) 2002-08-07 2010-12-22 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of Avipoxviruses
EP2371380A1 (en) 2003-03-28 2011-10-05 The Government of the United States of America, represented by The Secretary, Department of Health and Human Services MVA expressing modified hiv envelope, gag, and pol genes
WO2006026667A2 (en) 2004-08-27 2006-03-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes
WO2008138533A1 (en) 2007-05-14 2008-11-20 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
AU2010305030A1 (en) 2009-10-08 2012-05-10 Bavarian Nordic A/S Generation of a broad T-cell response in humans against HIV
WO2012010280A1 (en) 2010-07-20 2012-01-26 Bavarian Nordic A/S Method for harvesting expression products
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
EP3402802B1 (en) 2016-01-08 2023-04-12 Geovax, Inc. Compositions and methods for generating an immune response to a tumor associated antigen
EP4058058A1 (en) 2019-11-14 2022-09-21 Aelix Therapeutics S.L. Dosage regimens for vaccines
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein
EP4358999A1 (en) 2021-06-23 2024-05-01 Consejo Superior De Investigaciones Científicas Mva-based vaccine expressing a prefusion-stabilized sars-cov-2 s protein

Also Published As

Publication number Publication date
BE787901A (fr) 1972-12-18
CH568392A5 (enExample) 1975-10-31
AT320149B (de) 1975-01-27
DE2145477B2 (de) 1976-04-01
ES406590A1 (es) 1975-09-16
DK137392B (da) 1978-02-27
DE2145477A1 (de) 1973-03-15

Similar Documents

Publication Publication Date Title
DK137392C (da) Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination
DK114429B (da) Fremsgangmåde til fremstilling af et med kontrolleret frigørelse virkende terapeutisk præparat til oral brug.
DK145283C (da) Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen
DK138695C (da) Fremgangsmaade til fremstilling af pyrrolidon-5,5-difosfonsyrer og vandoploeselige salte heraf
SE7604818L (sv) Vaccin
AR193737A1 (es) Composicion glaseadora a base de fluoruro para esmalte dental
DK143437C (da) Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus
AR200895A1 (es) Procedimiento para preparar una vacuna de virus vivos respiratorios bovinos
DK135040C (da) Fremgangsmade til fremstilling af 2-amino-1,4-dihydropyridiner
NL7607958A (nl) Nieuw rabies virusvaccin en werkwijze ter bereiding daarvan.
BE794307A (fr) Vaccin anti-caries
BE781028R (fr) Adjuvants pour vaccins et preparations de vaccins les
TR16871A (tr) Ikis cesit yanisli emuelsiyonlu brueloerlerin isletilmesine mahsus usul
IT966747B (it) Procedimento per preparare dinitroantrachinoni
DK136778B (da) Fremgangsmade til fremstilling af aminholdige preparater af disazopigmenter af 3,3-dichlorbenzidinrekken
DK132447C (da) Fremgangsmade til fremstilling af kalvediarrevirusvaccine
DK132795C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK139521C (da) Fremgangsmaade til fremstilling af ren krystallinsk penicillinacylase
DK129590B (da) Fremgangsmåde til fremstilling af levende vaccine mod infektiøs bursitis hos høns.
DK132221C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK141055C (da) Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis
DK137118B (da) Fremgangsmade til fremstilling af et lh-rh-preparat til nasal applikation
BE771536A (fr) Preparation d'un vaccin
SE424503B (sv) Forfarande for framstellning av levande influensavirusvaccin typ b
DK146312C (da) Fremgangsmaade til fremstilling af en vaccine mod neonatal diarre